Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
53,041,500
-
Number of holders
-
3
-
Total 13F shares, excl. options
-
77,828
-
Shares change
-
+39,231
-
Total reported value, excl. options
-
$716,796
-
Value change
-
+$361,318
-
Number of buys
-
2
-
Price
-
$9.21
Institutional Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q4 2023
As of 31 Dec 2023 Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) had 151 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 77,828 shares of stock of the company.
Largest 10 holders included CAS Investment Partners, LLC, BlackRock Inc., VANGUARD GROUP INC, 683 Capital Management, LLC, KPS Global Asset Management UK Ltd, WORLDLY PARTNERS MANAGEMENT, LLC, MORGAN STANLEY, BAILLIE GIFFORD & CO, GEODE CAPITAL MANAGEMENT, LLC, and BRIGHTLIGHT CAPITAL MANAGEMENT LP.
This table shows 151 institutional shareholders of the security as of 31 Dec 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.